Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-05-14

FDA Approved: RETIN-A — Supplemental Application (Bausch Health US, LLC)

View source ↗

Summary

The FDA approved a supplemental application for RETIN-A (tretinoin) submitted by Bausch Health US, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Retin-A (tretinoin)

Snippet

SUPPL AP for RETIN-A (TRETINOIN)